nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.131	0.514	CbGbCtD
Bumetanide—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.124	0.486	CbGbCtD
Bumetanide—CFTR—sweat—chronic obstructive pulmonary disease	0.123	0.442	CbGeAlD
Bumetanide—Diuresis—Aminophylline—chronic obstructive pulmonary disease	0.0219	0.0584	CcSEcCtD
Bumetanide—SLC12A4—respiratory system—chronic obstructive pulmonary disease	0.014	0.0505	CbGeAlD
Bumetanide—CFTR—respiratory system—chronic obstructive pulmonary disease	0.011	0.0397	CbGeAlD
Bumetanide—PTGS2—leg—chronic obstructive pulmonary disease	0.0108	0.0387	CbGeAlD
Bumetanide—SLC12A2—respiratory system—chronic obstructive pulmonary disease	0.00969	0.0348	CbGeAlD
Bumetanide—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00912	0.0243	CcSEcCtD
Bumetanide—CFTR—bronchus—chronic obstructive pulmonary disease	0.00908	0.0326	CbGeAlD
Bumetanide—CFTR—trachea—chronic obstructive pulmonary disease	0.00815	0.0293	CbGeAlD
Bumetanide—CA7—trachea—chronic obstructive pulmonary disease	0.00803	0.0289	CbGeAlD
Bumetanide—SLC12A2—bronchus—chronic obstructive pulmonary disease	0.00797	0.0287	CbGeAlD
Bumetanide—SLC12A4—lung—chronic obstructive pulmonary disease	0.00746	0.0268	CbGeAlD
Bumetanide—Hyperuricaemia—Aminophylline—chronic obstructive pulmonary disease	0.00733	0.0195	CcSEcCtD
Bumetanide—SLC12A2—trachea—chronic obstructive pulmonary disease	0.00716	0.0257	CbGeAlD
Bumetanide—Hyperventilation—Salbutamol—chronic obstructive pulmonary disease	0.0071	0.0189	CcSEcCtD
Bumetanide—CA12—respiratory system—chronic obstructive pulmonary disease	0.00706	0.0254	CbGeAlD
Bumetanide—Blood uric acid increased—Aminophylline—chronic obstructive pulmonary disease	0.00692	0.0185	CcSEcCtD
Bumetanide—Glycosuria—Arformoterol—chronic obstructive pulmonary disease	0.00639	0.017	CcSEcCtD
Bumetanide—Glycosuria—Formoterol—chronic obstructive pulmonary disease	0.00639	0.017	CcSEcCtD
Bumetanide—CA12—connective tissue—chronic obstructive pulmonary disease	0.00621	0.0223	CbGeAlD
Bumetanide—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.00603	0.0161	CcSEcCtD
Bumetanide—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.00602	0.0161	CcSEcCtD
Bumetanide—CFTR—lung—chronic obstructive pulmonary disease	0.00586	0.0211	CbGeAlD
Bumetanide—Polyuria—Aminophylline—chronic obstructive pulmonary disease	0.00562	0.015	CcSEcCtD
Bumetanide—CA12—trachea—chronic obstructive pulmonary disease	0.00521	0.0188	CbGeAlD
Bumetanide—SLC12A2—lung—chronic obstructive pulmonary disease	0.00514	0.0185	CbGeAlD
Bumetanide—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.00507	0.0135	CcSEcCtD
Bumetanide—Musculoskeletal pain—Salbutamol—chronic obstructive pulmonary disease	0.00495	0.0132	CcSEcCtD
Bumetanide—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00449	0.012	CcSEcCtD
Bumetanide—CA4—respiratory system—chronic obstructive pulmonary disease	0.00437	0.0157	CbGeAlD
Bumetanide—Dehydration—Tiotropium—chronic obstructive pulmonary disease	0.00433	0.0115	CcSEcCtD
Bumetanide—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00428	0.0114	CcSEcCtD
Bumetanide—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.004	0.0107	CcSEcCtD
Bumetanide—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00385	0.0103	CcSEcCtD
Bumetanide—CA12—lung—chronic obstructive pulmonary disease	0.00375	0.0135	CbGeAlD
Bumetanide—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00363	0.00967	CcSEcCtD
Bumetanide—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00353	0.0094	CcSEcCtD
Bumetanide—Dehydration—Arformoterol—chronic obstructive pulmonary disease	0.00349	0.00931	CcSEcCtD
Bumetanide—Dehydration—Formoterol—chronic obstructive pulmonary disease	0.00349	0.00931	CcSEcCtD
Bumetanide—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00342	0.00911	CcSEcCtD
Bumetanide—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00342	0.00911	CcSEcCtD
Bumetanide—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.00338	0.00901	CcSEcCtD
Bumetanide—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.00338	0.00901	CcSEcCtD
Bumetanide—CA5B—lung—chronic obstructive pulmonary disease	0.00336	0.0121	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00331	0.00883	CcSEcCtD
Bumetanide—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.00331	0.00883	CcSEcCtD
Bumetanide—CA4—trachea—chronic obstructive pulmonary disease	0.00323	0.0116	CbGeAlD
Bumetanide—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00323	0.0086	CcSEcCtD
Bumetanide—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.00319	0.00851	CcSEcCtD
Bumetanide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00314	0.00836	CcSEcCtD
Bumetanide—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00312	0.00831	CcSEcCtD
Bumetanide—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00297	0.00793	CcSEcCtD
Bumetanide—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00293	0.0078	CcSEcCtD
Bumetanide—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00293	0.0078	CcSEcCtD
Bumetanide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00289	0.0077	CcSEcCtD
Bumetanide—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00288	0.00766	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00281	0.00749	CcSEcCtD
Bumetanide—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.00737	CcSEcCtD
Bumetanide—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.00267	0.00962	CbGeAlD
Bumetanide—SLCO1A2—lung—chronic obstructive pulmonary disease	0.00262	0.00943	CbGeAlD
Bumetanide—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00262	0.00698	CcSEcCtD
Bumetanide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00261	0.00696	CcSEcCtD
Bumetanide—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.00251	0.0067	CcSEcCtD
Bumetanide—Furosemide—ALB—chronic obstructive pulmonary disease	0.0025	0.582	CrCbGaD
Bumetanide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00249	0.00663	CcSEcCtD
Bumetanide—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00241	0.00641	CcSEcCtD
Bumetanide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00241	0.00641	CcSEcCtD
Bumetanide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00239	0.00636	CcSEcCtD
Bumetanide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00239	0.00636	CcSEcCtD
Bumetanide—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.00235	0.00847	CbGeAlD
Bumetanide—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00233	0.00622	CcSEcCtD
Bumetanide—CA4—lung—chronic obstructive pulmonary disease	0.00232	0.00834	CbGeAlD
Bumetanide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00231	0.00616	CcSEcCtD
Bumetanide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00229	0.00611	CcSEcCtD
Bumetanide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00229	0.00611	CcSEcCtD
Bumetanide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00228	0.00607	CcSEcCtD
Bumetanide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00227	0.00604	CcSEcCtD
Bumetanide—PTGS2—bronchus—chronic obstructive pulmonary disease	0.0022	0.00792	CbGeAlD
Bumetanide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00217	0.0058	CcSEcCtD
Bumetanide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00217	0.0058	CcSEcCtD
Bumetanide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00216	0.00576	CcSEcCtD
Bumetanide—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00215	0.00775	CbGeAlD
Bumetanide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00213	0.00568	CcSEcCtD
Bumetanide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.00547	CcSEcCtD
Bumetanide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00198	0.00529	CcSEcCtD
Bumetanide—PTGS2—trachea—chronic obstructive pulmonary disease	0.00198	0.00711	CbGeAlD
Bumetanide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00193	0.00514	CcSEcCtD
Bumetanide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00513	CcSEcCtD
Bumetanide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00513	CcSEcCtD
Bumetanide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00513	CcSEcCtD
Bumetanide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00513	CcSEcCtD
Bumetanide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.00511	CcSEcCtD
Bumetanide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00192	0.00511	CcSEcCtD
Bumetanide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00503	CcSEcCtD
Bumetanide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00188	0.00502	CcSEcCtD
Bumetanide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00188	0.00502	CcSEcCtD
Bumetanide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00187	0.00499	CcSEcCtD
Bumetanide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.00485	CcSEcCtD
Bumetanide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.00485	CcSEcCtD
Bumetanide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00182	0.00484	CcSEcCtD
Bumetanide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00181	0.00482	CcSEcCtD
Bumetanide—Fenoprofen—ALB—chronic obstructive pulmonary disease	0.0018	0.418	CrCbGaD
Bumetanide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00178	0.00474	CcSEcCtD
Bumetanide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00472	CcSEcCtD
Bumetanide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00173	0.0046	CcSEcCtD
Bumetanide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.0046	CcSEcCtD
Bumetanide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00172	0.00459	CcSEcCtD
Bumetanide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00172	0.00457	CcSEcCtD
Bumetanide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00449	CcSEcCtD
Bumetanide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00166	0.00442	CcSEcCtD
Bumetanide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00434	CcSEcCtD
Bumetanide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.00431	CcSEcCtD
Bumetanide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0016	0.00428	CcSEcCtD
Bumetanide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00424	CcSEcCtD
Bumetanide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00424	CcSEcCtD
Bumetanide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00156	0.00415	CcSEcCtD
Bumetanide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00154	0.00411	CcSEcCtD
Bumetanide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00153	0.00408	CcSEcCtD
Bumetanide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00153	0.00407	CcSEcCtD
Bumetanide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00152	0.00405	CcSEcCtD
Bumetanide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00151	0.00403	CcSEcCtD
Bumetanide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00402	CcSEcCtD
Bumetanide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00402	CcSEcCtD
Bumetanide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00401	CcSEcCtD
Bumetanide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00394	CcSEcCtD
Bumetanide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00391	CcSEcCtD
Bumetanide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00391	CcSEcCtD
Bumetanide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00389	CcSEcCtD
Bumetanide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00389	CcSEcCtD
Bumetanide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00145	0.00388	CcSEcCtD
Bumetanide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.00384	CcSEcCtD
Bumetanide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.00384	CcSEcCtD
Bumetanide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00144	0.00384	CcSEcCtD
Bumetanide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00144	0.00383	CcSEcCtD
Bumetanide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00143	0.00382	CcSEcCtD
Bumetanide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00381	CcSEcCtD
Bumetanide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.0038	CcSEcCtD
Bumetanide—PTGS2—lung—chronic obstructive pulmonary disease	0.00142	0.00511	CbGeAlD
Bumetanide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00369	CcSEcCtD
Bumetanide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00367	CcSEcCtD
Bumetanide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00362	CcSEcCtD
Bumetanide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00359	CcSEcCtD
Bumetanide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00353	CcSEcCtD
Bumetanide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00353	CcSEcCtD
Bumetanide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00348	CcSEcCtD
Bumetanide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00348	CcSEcCtD
Bumetanide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00346	CcSEcCtD
Bumetanide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00341	CcSEcCtD
Bumetanide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00337	CcSEcCtD
Bumetanide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00337	CcSEcCtD
Bumetanide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00334	CcSEcCtD
Bumetanide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00333	CcSEcCtD
Bumetanide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00124	0.0033	CcSEcCtD
Bumetanide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00329	CcSEcCtD
Bumetanide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00325	CcSEcCtD
Bumetanide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00325	CcSEcCtD
Bumetanide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00319	CcSEcCtD
Bumetanide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00318	CcSEcCtD
Bumetanide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00313	CcSEcCtD
Bumetanide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00313	CcSEcCtD
Bumetanide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00116	0.0031	CcSEcCtD
Bumetanide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.0031	CcSEcCtD
Bumetanide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00116	0.0031	CcSEcCtD
Bumetanide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.0031	CcSEcCtD
Bumetanide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00308	CcSEcCtD
Bumetanide—Headache—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00308	CcSEcCtD
Bumetanide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00307	CcSEcCtD
Bumetanide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00307	CcSEcCtD
Bumetanide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00306	CcSEcCtD
Bumetanide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00304	CcSEcCtD
Bumetanide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00304	CcSEcCtD
Bumetanide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00302	CcSEcCtD
Bumetanide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00295	CcSEcCtD
Bumetanide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.0011	0.00293	CcSEcCtD
Bumetanide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00293	CcSEcCtD
Bumetanide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00293	CcSEcCtD
Bumetanide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00292	CcSEcCtD
Bumetanide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00292	CcSEcCtD
Bumetanide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00291	CcSEcCtD
Bumetanide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00286	CcSEcCtD
Bumetanide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00276	CcSEcCtD
Bumetanide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000967	0.00258	CcSEcCtD
Bumetanide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.0008	0.00213	CcSEcCtD
Bumetanide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000794	0.00212	CcSEcCtD
Bumetanide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000758	0.00202	CcSEcCtD
Bumetanide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000702	0.00187	CcSEcCtD
Bumetanide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000661	0.00176	CcSEcCtD
Bumetanide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00063	0.00168	CcSEcCtD
Bumetanide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00063	0.00168	CcSEcCtD
Bumetanide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000626	0.00167	CcSEcCtD
Bumetanide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000626	0.00167	CcSEcCtD
Bumetanide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000594	0.00158	CcSEcCtD
Bumetanide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000594	0.00158	CcSEcCtD
Bumetanide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000577	0.00154	CcSEcCtD
Bumetanide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000574	0.00153	CcSEcCtD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000549	0.00631	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000549	0.0063	CbGpPWpGaD
Bumetanide—SLCO1A2—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.000546	0.00627	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000545	0.00626	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000544	0.00625	CbGpPWpGaD
Bumetanide—CA14—Metabolism—APIP—chronic obstructive pulmonary disease	0.000533	0.00613	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000528	0.00606	CbGpPWpGaD
Bumetanide—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000523	0.00601	CbGpPWpGaD
Bumetanide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000521	0.00139	CcSEcCtD
Bumetanide—CA5A—Metabolism—APIP—chronic obstructive pulmonary disease	0.00052	0.00597	CbGpPWpGaD
Bumetanide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000514	0.00137	CcSEcCtD
Bumetanide—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000513	0.0059	CbGpPWpGaD
Bumetanide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000497	0.00132	CcSEcCtD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000486	0.00558	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—APIP—chronic obstructive pulmonary disease	0.000485	0.00557	CbGpPWpGaD
Bumetanide—CA7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000485	0.00557	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000484	0.00556	CbGpPWpGaD
Bumetanide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00048	0.00128	CcSEcCtD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000467	0.00537	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000466	0.00536	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000465	0.00534	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000465	0.00534	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000465	0.00534	CbGpPWpGaD
Bumetanide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000462	0.00123	CcSEcCtD
Bumetanide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000458	0.00122	CcSEcCtD
Bumetanide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000458	0.00122	CcSEcCtD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000455	0.00523	CbGpPWpGaD
Bumetanide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000455	0.00121	CcSEcCtD
Bumetanide—CA12—Metabolism—APIP—chronic obstructive pulmonary disease	0.00045	0.00516	CbGpPWpGaD
Bumetanide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000435	0.00499	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000432	0.00496	CbGpPWpGaD
Bumetanide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000432	0.00115	CcSEcCtD
Bumetanide—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000415	0.00477	CbGpPWpGaD
Bumetanide—SLC22A7—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000408	0.00469	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000406	0.00466	CbGpPWpGaD
Bumetanide—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000401	0.00461	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.0004	0.0046	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000399	0.00458	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000398	0.00457	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000395	0.00454	CbGpPWpGaD
Bumetanide—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000379	0.00435	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000376	0.00432	CbGpPWpGaD
Bumetanide—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000373	0.00428	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000363	0.00417	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APIP—chronic obstructive pulmonary disease	0.000359	0.00412	CbGpPWpGaD
Bumetanide—CA14—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000353	0.00406	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000344	0.00395	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GC—chronic obstructive pulmonary disease	0.000344	0.00395	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GC—chronic obstructive pulmonary disease	0.000335	0.00385	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000325	0.00373	CbGpPWpGaD
Bumetanide—CA7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000321	0.00369	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000321	0.00369	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00032	0.00367	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GC—chronic obstructive pulmonary disease	0.000313	0.00359	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GC—chronic obstructive pulmonary disease	0.000313	0.00359	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000311	0.00358	CbGpPWpGaD
Bumetanide—CA12—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000298	0.00342	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.000293	0.00337	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000291	0.00334	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000291	0.00334	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APIP—chronic obstructive pulmonary disease	0.00029	0.00333	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GC—chronic obstructive pulmonary disease	0.00029	0.00333	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000279	0.00321	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000279	0.00321	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000279	0.00321	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000278	0.00319	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000269	0.00309	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000268	0.00308	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000268	0.00307	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000262	0.00301	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.00026	0.00298	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000249	0.00286	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000247	0.00284	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000242	0.00278	CbGpPWpGaD
Bumetanide—CA4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000238	0.00273	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000237	0.00273	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000235	0.0027	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GC—chronic obstructive pulmonary disease	0.000231	0.00265	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000225	0.00259	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000215	0.00247	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000215	0.00247	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.00021	0.00242	CbGpPWpGaD
Bumetanide—CA9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000192	0.0022	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000188	0.00216	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000187	0.00214	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GC—chronic obstructive pulmonary disease	0.000187	0.00214	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000186	0.00213	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000185	0.00212	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000183	0.0021	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000181	0.00208	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000179	0.00206	CbGpPWpGaD
Bumetanide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000176	0.00202	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000174	0.00199	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000171	0.00196	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000171	0.00196	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000169	0.00195	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000169	0.00194	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000169	0.00194	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000168	0.00193	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000166	0.0019	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000165	0.0019	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000163	0.00187	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000162	0.00186	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000162	0.00186	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000161	0.00185	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.00016	0.00184	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.00016	0.00183	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000158	0.00182	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000156	0.0018	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.00179	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000154	0.00177	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000154	0.00177	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.00175	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000152	0.00174	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.00015	0.00173	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.00015	0.00172	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	0.000147	0.00169	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000143	0.00164	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00163	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00163	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000141	0.00162	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00014	0.00161	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000132	0.00152	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000132	0.00151	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.00151	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000131	0.00151	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000131	0.0015	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00013	0.00149	CbGpPWpGaD
Bumetanide—CA14—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000128	0.00147	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000127	0.00146	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000127	0.00146	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000126	0.00145	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000126	0.00145	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000125	0.00144	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000125	0.00143	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000122	0.00141	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000122	0.0014	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.0014	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	0.00012	0.00138	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.00012	0.00137	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000119	0.00137	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GC—chronic obstructive pulmonary disease	0.000119	0.00137	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000118	0.00136	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000118	0.00136	CbGpPWpGaD
Bumetanide—CA7—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000117	0.00134	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000117	0.00134	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000117	0.00134	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000114	0.00131	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.0013	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000112	0.00129	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000112	0.00128	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000111	0.00127	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00127	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00126	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00011	0.00126	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000109	0.00125	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000109	0.00125	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000108	0.00124	CbGpPWpGaD
Bumetanide—CA12—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000108	0.00124	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000107	0.00123	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000106	0.00121	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.0012	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000104	0.00119	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00118	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00118	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000102	0.00117	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000101	0.00116	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000101	0.00116	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	9.79e-05	0.00112	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.56e-05	0.0011	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	9.53e-05	0.00109	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.5e-05	0.00109	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CTGF—chronic obstructive pulmonary disease	9.2e-05	0.00106	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.17e-05	0.00105	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	9.05e-05	0.00104	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.04e-05	0.00104	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.93e-05	0.00103	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.83e-05	0.00101	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.75e-05	0.001	CbGpPWpGaD
Bumetanide—CA4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.63e-05	0.000991	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.48e-05	0.000973	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.43e-05	0.000968	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.42e-05	0.000968	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	8.28e-05	0.000951	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	8.07e-05	0.000927	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.04e-05	0.000923	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.99e-05	0.000918	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.96e-05	0.000914	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	7.91e-05	0.000908	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ALB—chronic obstructive pulmonary disease	7.71e-05	0.000885	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.69e-05	0.000883	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.64e-05	0.000878	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.62e-05	0.000875	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	7.53e-05	0.000865	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ALB—chronic obstructive pulmonary disease	7.51e-05	0.000863	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.4e-05	0.00085	CbGpPWpGaD
Bumetanide—CA14—Metabolism—NOS3—chronic obstructive pulmonary disease	7.37e-05	0.000847	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.34e-05	0.000843	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	7.2e-05	0.000826	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—NOS3—chronic obstructive pulmonary disease	7.19e-05	0.000825	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.07e-05	0.000812	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ALB—chronic obstructive pulmonary disease	7.01e-05	0.000805	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	7.01e-05	0.000805	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.97e-05	0.000801	CbGpPWpGaD
Bumetanide—CA7—Metabolism—NOS3—chronic obstructive pulmonary disease	6.71e-05	0.00077	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	6.71e-05	0.00077	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.69e-05	0.000768	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	6.64e-05	0.000763	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.51e-05	0.000748	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.5e-05	0.000746	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	6.5e-05	0.000746	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.43e-05	0.000739	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.42e-05	0.000738	CbGpPWpGaD
Bumetanide—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	6.21e-05	0.000714	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.16e-05	0.000707	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	6.08e-05	0.000698	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6e-05	0.000689	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.98e-05	0.000687	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.87e-05	0.000674	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.7e-05	0.000655	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5.49e-05	0.00063	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.43e-05	0.000624	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.41e-05	0.000621	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.38e-05	0.000618	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.36e-05	0.000616	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.33e-05	0.000612	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.19e-05	0.000597	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	5.18e-05	0.000595	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	5.12e-05	0.000589	CbGpPWpGaD
Bumetanide—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.96e-05	0.000569	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.52e-05	0.000519	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.51e-05	0.000518	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.45e-05	0.000511	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	4.19e-05	0.000481	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.15e-05	0.000476	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	4e-05	0.00046	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	3.95e-05	0.000453	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.93e-05	0.000452	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.93e-05	0.000451	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.89e-05	0.000446	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KL—chronic obstructive pulmonary disease	3.67e-05	0.000421	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.62e-05	0.000416	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.55e-05	0.000407	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.27e-05	0.000375	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	2.75e-05	0.000316	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.72e-05	0.000313	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.69e-05	0.000309	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.67e-05	0.000307	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.56e-05	0.000294	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.5e-05	0.000288	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.37e-05	0.000273	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	2.29e-05	0.000263	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	1.93e-05	0.000222	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	1.84e-05	0.000212	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	1.61e-05	0.000185	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.54e-05	0.000177	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	1.22e-05	0.00014	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	1.19e-05	0.000137	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	9.18e-06	0.000105	CbGpPWpGaD
